Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Coretal
2. Hydrochloride, Oxprenolol
3. Koretal
4. Oxprenolol
5. Slow Trasicor
6. Tevacor
7. Trasicor
8. Trasicor, Slow
1. 6452-73-9
2. Trasicor
3. Oxprenolol Hcl
4. Evinrozit
5. Ranidrox
6. Rixiprol
7. Coretal
8. Oxprenolol.hcl
9. Ba-39089
10. Ciba 39089ba
11. F4xsi7sniu
12. Oxprenolol (hydrochloride)
13. 2-propanol, 1-(o-allyloxyphenoxy)-3-isopropylamino-, Hydrochloride
14. Ba-39,089
15. 1-(o-allyloxyphenoxy)-3-isopropylamino-2-propanol Hydrochloride
16. 1-(2-(allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol Hydrochloride
17. (+/-)-oxprenolol (hydrochloride)
18. 1-(propan-2-ylamino)-3-(2-prop-2-enoxyphenoxy)propan-2-ol;hydrochloride
19. Secondafil
20. Vrachor
21. Flecor
22. Slow-trasicor
23. Dsstox_cid_1093
24. (+/-)-ba 39089
25. Dsstox_rid_75936
26. Dsstox_gsid_21093
27. Oxiprenolol Hydrochloride
28. Dl-alprenolol Hydrochloride
29. Ccris 1097
30. Unii-f4xsi7sniu
31. C-39089-ba
32. Einecs 229-260-5
33. Einecs 245-358-0
34. Ba 39089
35. (+-)-ba 39089
36. Okuspurecol (tn)
37. Oxprenolol Hydrochloride [usan:usp:jan]
38. Dl-1-(2-allylphenoxy)-3-isopropylaminopropan-2-ol Hydrochloride
39. Ncgc00016675-01
40. 2-(o-allyloxyphenoxy)-2-hydroxy-n-isopropyl-1-propylamine Hydrochloride
41. 2-propanol, 1-(o-(allyloxy)phenoxy)-3-(isopropylamino)-, Hydrochloride, (+-)-
42. Cas-6452-73-9
43. 2-propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, Hydrochloride
44. 2-propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyloxy)phenoxy)-, Hydrochloride, (+-)-
45. Mls002154132
46. Schembl123517
47. Chembl1200745
48. Dtxsid5021093
49. Hms1571c16
50. Hy-b1486
51. Tox21_110556
52. Mfcd00058008
53. Oxprenolol Hydrochloride [mi]
54. Oxprenolol Hydrochloride (jp17/usp)
55. Oxprenolol Hydrochloride [jan]
56. (1)-(3-(2-(allyloxy)phenoxy)-2-hydroxypropyl)isopropylammonium Chloride
57. Akos015994696
58. Tox21_110556_1
59. Ccg-221057
60. Ks-1152
61. Oxprenolol Hydrochloride [usan]
62. 1-[(1-methylethyl)amino]-3-{[2-(prop-2-en-1-yloxy)phenyl]oxy}propan-2-ol Hydrochloride
63. Ncgc00179342-03
64. Oxprenolol Hydrochloride [usp-rs]
65. Oxprenolol Hydrochloride [who-dd]
66. 22972-97-0
67. Smr001233439
68. Db-054683
69. Cs-0013185
70. Ft-0630349
71. Sw219956-1
72. Oxprenolol Hydrochloride [ep Impurity]
73. Oxprenolol Hydrochloride [orange Book]
74. D01806
75. Oxprenolol Hydrochloride [usp Impurity]
76. Oxprenolol Hydrochloride [usp Monograph]
77. Sr-01000841263
78. Sr-01000841263-2
79. Q27277643
80. Oxprenolol Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
81. 1-(2-(allyloxy)phenoxy)-3-(isopropylamino)propan-2-ol Hcl
82. 1-(isopropylamino)-2-hydroxy-3-[o-(allyloxy)phenoxy]propane Hydrochloride
83. 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-2-propanol Hydrochloride
84. 1-[(1-methylethyl)amino]-3-[2-(2-propenyloxy)phenoxy]-2-propanol Hydrochloride
85. 2-propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yloxy)phenoxy]-, Hydrochloride (1:1)
Molecular Weight | 301.81 g/mol |
---|---|
Molecular Formula | C15H24ClNO3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 301.1444713 g/mol |
Monoisotopic Mass | 301.1444713 g/mol |
Topological Polar Surface Area | 50.7 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 246 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Sympatholytics
Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)
Global Sales Information
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
43
PharmaCompass offers a list of Oxprenolol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxprenolol manufacturer or Oxprenolol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxprenolol manufacturer or Oxprenolol supplier.
PharmaCompass also assists you with knowing the Oxprenolol API Price utilized in the formulation of products. Oxprenolol API Price is not always fixed or binding as the Oxprenolol Price is obtained through a variety of data sources. The Oxprenolol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxprenolol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxprenolol Hydrochloride, including repackagers and relabelers. The FDA regulates Oxprenolol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxprenolol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxprenolol Hydrochloride supplier is an individual or a company that provides Oxprenolol Hydrochloride active pharmaceutical ingredient (API) or Oxprenolol Hydrochloride finished formulations upon request. The Oxprenolol Hydrochloride suppliers may include Oxprenolol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Oxprenolol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxprenolol Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxprenolol Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Oxprenolol Hydrochloride DMFs exist exist since differing nations have different regulations, such as Oxprenolol Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxprenolol Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Oxprenolol Hydrochloride USDMF includes data on Oxprenolol Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxprenolol Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxprenolol Hydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxprenolol Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxprenolol Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxprenolol Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxprenolol Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxprenolol Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxprenolol Hydrochloride suppliers with NDC on PharmaCompass.
Oxprenolol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxprenolol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxprenolol Hydrochloride GMP manufacturer or Oxprenolol Hydrochloride GMP API supplier for your needs.
A Oxprenolol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Oxprenolol Hydrochloride's compliance with Oxprenolol Hydrochloride specifications and serves as a tool for batch-level quality control.
Oxprenolol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Oxprenolol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxprenolol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxprenolol Hydrochloride EP), Oxprenolol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxprenolol Hydrochloride USP).